InvestorsHub Logo
Followers 14
Posts 6158
Boards Moderated 0
Alias Born 06/14/2014

Re: None

Tuesday, 11/24/2015 3:09:19 PM

Tuesday, November 24, 2015 3:09:19 PM

Post# of 144812
more PMCB smoke and mirrors
Orphan designation
Key facts
Review of designation

On 30 June 2003, orphan designation (EU/3/03/149) was granted by the European Commission to FSG-Biotechnologie GmbH, Austrianova, Austria, for cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate for the treatment of pancreatic cancer in combination with ifosfamide.
FSG Biotechnologie Austrianova GmbH changed its name to Austrianova Biotechnology GmbH in 2005.
The sponsorship was transferred to Ziel Biopharma Limited, Ireland, in December 2008.

PMCB didn't tell anyone in today's PR that this was just a transfer
did nothing with it in 2003 and will do nothing with it 12 years later
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News